New post-doctorate
We are happy to welcome Dr Julia Fath as a postdoctoral researcher in the SNP group. She will work on the “CadoRNA” ANR project to develop Carbon Dot-based nanoparticles for siRNA delivery and enhanced PDT. News SNP
New PhD fellowship
We are happy to welcome Élise Cherasse, she started her thesis in October 2024 in the SNP group. Her research will involve the development of Carbon Dots for siRNA delivery and enhanced PDT delivery. News SNP
![[Translate to English:] Fanny Burger](/websites/_processed_/2/5/csm_Fanny_Burger_32631642a4.jpeg "© Fanny Burger")
New PhD fellowship
Congratulations to Fanny Burger, master student in pharmacology and toxicology at the Faculty of Pharmacy of Strasbourg, for obtaining a disability doctoral fellowship from the University of Strasbourg. Fanny will start her PhD next October in the SNP team on the delivery of siRNA controlled by…
New PhD fellowship
Congratulations to Léa Garcenot, Master's student in Molecular and Supramolecular Chemistry at the Faculty of Chemistry of Strasbourg, for obtaining a doctoral contract from the Strasbourg Doctoral School of Chemical Sciences. Léa will start her PhD next October in the SNP team on the development of…
The ANR project “CadoRNA” started in march 2024
The “CadoRNA” ANR project funded in 2023 (project ANR-23-CE18-0014) started start in March 2024. This research project coordinated by Alexandre Specht will be carried out in collaboration with the groups of Françoise Pons, Pascal Didier (LBP, UMR 7021) and Mei Li (IGBMC, UMR 7104 – UMR-S 1258).…
The SATT Conectus Alsace Maturation project “MucoLip” started in march 2024
Following a pre-maturation phase, the “MucoLip” project (Project leaders: Françoise Pons & Luc Lebeau) entered in a maturation phase (funding from SATT Conectus Alsace). This project aims to develop auxiliary lipids to confer intrinsic mucolytic activity to lipidic nanoparticles for the release of…
Light Targeted transgene expression in the eye validated in a mouse model
In this work carried out in collaboration with the team of Dr. Sidney Cambridge at the University of Frankfurt, we demonstrate a first step towards the development of targeted light-mediated gene therapy in the eye.